Results 151 to 160 of about 39,902 (221)

Cross-national biologic treatment guidelines for FMF: a comparative analysis. [PDF]

Rheumatology (Oxford)
Kasap Cuceoglu M, Hinze T, Wittkowski H, Haslak F, Mamutova A, Oner N, Caorsi R, Bourguiba R, Elhani I, Delplanque M, El Moussaoui M, Pateras K, Sestan M, Kirijas M, Constantin T, Ducharme-Benard S, Lanchmann H, Butbul Aviel Y, Hentgen V.   +18 more
europepmc   +1 more source

Development of a mobile health application to support the management of paediatric FMF. [PDF]

Rheumatology (Oxford)
Bayrak YE, Özcan H, Pir F, Şahin N, Aydın D, Sönmez HE.   +5 more
europepmc   +1 more source

Successful Management of Accidental Colchicine Intoxication After Ingestion of <i>Colchicum autumnale</i>: A Case Report. [PDF]

Toxics
Kovács-Ábrahám Z, Aczél T, Lakner B, Ónodi M, Csontos C, Németh M.   +5 more
europepmc   +1 more source

Effect of Colchicine Use and Usual Care Alone on the Rate of Progression to Chronic Kidney Disease and Mortality in Patients with Heat-Related Injury. [PDF]

Healthcare (Basel)
Tseng MF, Chung CH, Chien WC, Hwang SJ, Chiou YS, Wu CC.   +5 more
europepmc   +1 more source

Colchicine [PDF]

, 2020
openaire   +1 more source

Effects of anti-inflammatory agents on cardiovascular outcomes: A systematic review and meta-analysis of randomised controlled trials. [PDF]

Am J Prev Cardiol
Perkovic A, Webster ER, Ridker PM, Tuttle KR, Perkovic V, Neuen BL.   +5 more
europepmc   +1 more source

Colchicine in addition to usual care for acute pericarditis with classical ECG changes after catheter ablation for cardiac arrhythmias. [PDF]

Am Heart J Plus
Toniolo M, Rebellato L, Imazio M.
europepmc   +1 more source

Targeting NLRP3 Inflammasomes in Myocarditis: Potential Therapeutic Strategies and Clinical Translation. [PDF]

Scientifica (Cairo)
Retnowati FD, Halawa DR, Maayah ZH, Abdallah AM.   +3 more
europepmc   +1 more source

The effect of IL-1 blockers on exertional leg pain in familial Mediterranean fever patients: an exploratory study. [PDF]

Rheumatology (Oxford)
Druyan A, Livneh A, Giat E, Ben-Zvi I, Lidar M.   +4 more
europepmc   +1 more source

Validation of the SMART-REACH model after stroke and the effect of colchicine by atherosclerotic cardiovascular disease risk category: a secondary analysis of the CONVINCE randomised clinical trial. [PDF]

Eur Stroke J
Maes L, Verschuere C, Walsh C, Weimar C, Purroy F, Price C, Fonseca C, Hill MD, Jatuzis D, Kõrv J, Kruuse C, Mikulik R, Nederkoorn P, Czlonkowska A, Fischer U, McCormick M, Castellanos M, Baptista M, Marto JP, Thavanesan K, Williams DJ, Kelly P, Lemmens R, CONVINCE investigators .   +23 more
europepmc   +1 more source